Re:Cognition Health - Fort Worth — Fort Worth, Texas

Re:Cognition Health - Fort Worth is a clinical research site located in Fort Worth, Texas, United States 76104.

Crixeo Health Trust Score: 71/100 (FAIR). This profile has not yet been claimed by the site owner.

Re:Cognition Health - Fort Worth has participated in 7 clinical trials with 7 currently active.

Therapeutic areas: Diabetic Peripheral Neuropathic Pain, Alzheimers Disease, Depressive Disorder, Major.

Sponsors: Eli Lilly and Company, Hoffmann-La Roche, Ono Pharmaceutical Co. Ltd.

Sponsor Feasibility Report

Trust Score: 71/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Re:Cognition Health - Fort Worth?

Re:Cognition Health - Fort Worth has a Crixeo Trust Score of 71/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Re:Cognition Health - Fort Worth conducted?

Re:Cognition Health - Fort Worth has 7 clinical trials on record, with 7 currently active. Their work covers Diabetic Peripheral Neuropathic Pain, Alzheimers Disease, Depressive Disorder, Major.

Is Re:Cognition Health - Fort Worth accredited by Crixeo Health?

Yes — Re:Cognition Health - Fort Worth holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Re:Cognition Health - Fort Worth?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.